AbbVieABBVEarnings & Financial Report
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
ABBV Q3 2025 Key Financial Metrics
Revenue
$15.8B
Gross Profit
$10.5B
Operating Profit
$1.9B
Net Profit
$186.0M
Gross Margin
66.4%
Operating Margin
12.1%
Net Margin
1.2%
YoY Growth
9.1%
EPS
$0.10
Financial Flow
AbbVie Q3 2025 Financial Summary
AbbVie reported revenue of $15.8B for Q3 2025, with a net profit of $186.0M (1.2% margin). Cost of goods sold was $5.3B, operating expenses totaled $8.6B.
Key Financial Metrics
| Total Revenue | $15.8B |
|---|---|
| Net Profit | $186.0M |
| Gross Margin | 66.4% |
| Operating Margin | 12.1% |
| Report Period | Q3 2025 |
AbbVie Annual Revenue by Year
AbbVie annual revenue history includes year-by-year totals (for example, 2024 revenue was $56.3B).
| Year | Annual Revenue |
|---|---|
| 2024 | $56.3B |
| 2023 | $54.3B |
| 2022 | $58.1B |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.30B | $12.31B | $14.46B | $14.46B | $15.10B | $13.34B | $15.42B | $15.78B |
| YoY Growth | -5.4% | 0.7% | 4.3% | 3.8% | 5.6% | 8.4% | 6.6% | 9.1% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $134.71B | $148.87B | $141.94B | $143.42B | $135.16B | $136.16B | $137.18B | $133.90B |
| Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Equity | $10.36B | $8.01B | $6.78B | $6.03B | $3.33B | $1.42B | $-183.0M | $-2.64B |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $4.75B | $4.04B | $2.27B | $5.45B | $7.05B | $1.64B | $5.15B | $7.02B |
Other Health Care Companies
AMGN
Amgen
Revenue
$9.9B
Net Profit
$1.3B
BIIB
Biogen
Revenue
$2.3B
Net Profit
$-48.9M
GILD
Gilead Sciences
Revenue
$7.8B
Net Profit
$3.1B
INCY
Incyte
Revenue
$1.5B
Net Profit
$299.3M
MRNA
Moderna
Revenue
$1.0B
Net Profit
$-200.0M
REGN
Regeneron Pharmaceuticals
Revenue
$3.9B
Net Profit
$844.6M
VRTX
Vertex Pharmaceuticals
Revenue
$3.2B
Net Profit
$1.2B
ABT
Abbott Laboratories
Revenue
$11.4B
Net Profit
$1.6B
A
Agilent Technologies
Revenue
$1.9B
Net Profit
$434.0M
ALGN
Align Technology
Revenue
$995.7M
Net Profit
$56.8M